Real‐Time Nanoplasmonic Sensor for IgG Monitoring in Bioproduction
Abstract
Real-time monitoring of product titers during process development and production of biotherapeutics facilitate implementation of quality-by-design principles and enable rapid bioprocess decision and optimization of the production process. Conventional analytical methods are generally performed offline/at-line and, therefore, are not capable of generating real-time data. In this study, a novel fiber optical nanoplasmonic sensor technology was explored for rapid IgG titer measurements. The sensor combines localized surface plasmon resonance transduction and robust single use Protein A-modified sensor chips, housed in a flexible flow cell, for specific IgG detection. The sensor requires small sample volumes (1–150 µL) and shows a reproducibility and sensitivity comparable to Protein G high performance liquid chromatography-ultraviolet (HPLC-UV). The dynamic range of the sensor system can be tuned by varying the sample volume, which enables quantification of IgG samples ranging from 0.0015 to 10 mg/mL, without need for sample dilution. The sensor shows limited interference from the sample matrix and negligible unspecific protein binding. IgG titers can be rapidly determined in samples from filtered unpurified Chinese hamster ovary (CHO) cell cultures and show good correlation with enzyme-linked immunosorbent assay (ELISA).
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
LSPR biosensors have a short response time (measurements in a few seconds), a large tunable dynamic range, and little need for sample pretreatment.
“It also has a short response time where the measurements can be done in a few seconds and a large, tunable dynamic range with little need for sample pretreatment [99].”
From Current PAT Landscape in the Downstream Processing of Biopharmaceuticals (2025) · cites this paper as [99]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
No references could be resolved yet.
Research works printed but not linked: 38
- Rathore, A.S.; Bhambure, R.; Ghare, V. Process analytical technology (PAT) for biopharmaceutical products. Anal. Bioanal. Chem. 2010, 398, 137-154, doi:10.1007/s00216-010-3781-x. · DOI
- Glassey, J.; Gernaey, K.V.; Clemens, C.; Schulz, T.W.; Oliveira, R.; Striedner, G.; Mandenius, C.F. Process analytical technology (PAT) for biopharmaceuticals. Biotechnol. J. 2011, 6, 369-377, doi:10.1002/biot.201000356. · DOI
- Guerra, A.; Von Stosch, M.; Glassey, J. Toward biotherapeutic product real-time quality monitoring. Crit. Rev. Biotechnol. 2019, 39, 289-305, doi:10.1080/07388551.2018.1524362. · DOI · Paper page
- Kesik-Brodacka, M. Progress in biopharmaceutical development. Biotechnol. Appl. Biochem. 2018, 65, 306- 322, doi:10.1002/bab.1617. · DOI
- Tsumoto, K.; Isozaki, Y.; Yagami, H.; Tomita, M. Future perspectives of therapeutic monoclonal antibodies. Immunotherapy 2019, 11, 119-127, doi:10.2217/imt-2018-0130. · DOI
- Shukla, A.A.; Wolfe, L.S.; Mostafa, S.S.; Norman, C. Evolving trends in mAb production processes. Bioeng. Transl. Med. 2017, 2, 58-69, doi:10.1002/btm2.10061. · DOI
- Rathore, A.S.; Bhambure, R.; Ghare, V. Process analytical technology (PAT) for biopharmaceutical products. Anal. Bioanal. Chem. 2010, 398, 137-154, doi:10.1007/s00216-010-3781-x. · DOI
- Glassey, J.; Gernaey, K.V.; Clemens, C.; Schulz, T.W.; Oliveira, R.; Striedner, G.; Mandenius, C.F. Process analytical technology (PAT) for biopharmaceuticals. Biotechnol. J. 2011, 6, 369-377, doi:10.1002/biot.201000356. · DOI
- Guerra, A.; Von Stosch, M.; Glassey, J. Toward biotherapeutic product real-time quality monitoring. Crit. Rev. Biotechnol. 2019, 39, 289-305, doi:10.1080/07388551.2018.1524362. · DOI
- Kesik-Brodacka, M. Progress in biopharmaceutical development. Biotechnol. Appl. Biochem. 2018, 65, 306- 322, doi:10.1002/bab.1617. · DOI · Paper page
- Tsumoto, K.; Isozaki, Y.; Yagami, H.; Tomita, M. Future perspectives of therapeutic monoclonal antibodies. Immunotherapy 2019, 11, 119-127, doi:10.2217/imt-2018-0130. · DOI
- Shukla, A.A.; Wolfe, L.S.; Mostafa, S.S.; Norman, C. Evolving trends in mAb production processes. Bioeng. Transl. Med. 2017, 2, 58-69, doi:10.1002/btm2.10061. · DOI
- Rathore, A.S.; Bhambure, R.; Ghare, V. Process analytical technology (PAT) for biopharmaceutical products. Anal. Bioanal. Chem. 2010, 398, 137-154. [CrossRef] · DOI
- Glassey, J.; Gernaey, K.V.; Clemens, C.; Schulz, T.W.; Oliveira, R.; Striedner, G.; Mandenius, C.F. Process analytical technology (PAT) for biopharmaceuticals. Biotechnol. J. 2011, 6, 369-377. [CrossRef] · DOI
- Guerra, A.; Von Stosch, M.; Glassey, J. Toward biotherapeutic product real-time quality monitoring. Crit. Rev. Biotechnol. 2019, 39, 289-305. [CrossRef] · DOI · Paper page
- Kesik-Brodacka, M. Progress in biopharmaceutical development. Biotechnol. Appl. Biochem. 2018, 65, 306-322. [CrossRef] · DOI
- Tsumoto, K.; Isozaki, Y.; Yagami, H.; Tomita, M. Future perspectives of therapeutic monoclonal antibodies. Immunotherapy 2019, 11, 119-127. [CrossRef] [PubMed] · DOI
- Shukla, A.A.; Wolfe, L.S.; Mostafa, S.S.; Norman, C. Evolving trends in mAb production processes. Bioeng. Transl. Med. 2017, 2, 58-69. [CrossRef] [PubMed] · DOI
- Kunert, R.; Reinhart, D. Advances in recombinant antibody manufacturing. Appl. Microbiol. Biotechnol. 2016, 100, 3451-3461. [CrossRef] [PubMed] · DOI
- Huang, Y.-M.; Hu, W.; Rustandi, E.; Chang, K.; Yusuf-Makagiansar, H.; Ryll, T. Maximizing productivity of CHO cell-based fed-batch culture using chemically defined media conditions and typical manufacturing equipment. Biotechnol. Prog. 2010, 26, 1400-1410. [CrossRef] [PubMed] · DOI
- Reinhart, D.; Damjanovic, L.; Kaisermayer, C.; Kunert, R. Benchmarking of commercially available CHO cell culture media for antibody production. Appl. Microbiol. Biotechnol. 2015, 99, 4645-4657. [CrossRef] · DOI
- Mushens, R.E.; Guest, A.R.; Scott, M.L. Quantitation of monoclonal antibodies by ELISA: The use of purified mouse IgG and mouse IgM monoclonal antibodies as standards in a quantitative ELISA measuring monoclonal antibodies produced by cell culture. J. Immunol. Methods 1993, 162, 77-83. [CrossRef] · DOI
- Horak, J.; Ronacher, A.; Lindner, W. Quantification of immunoglobulin G and characterization of process related impurities using coupled Protein A and size exclusion high performance liquid chromatography. J. Chromatogr. A 2010, 1217, 5092-5102. [CrossRef] [PubMed] · DOI
- Fernández, L.P.; Calvo, L.; Viña, L. Development and Validation of an Affinity Chromatography-Protein G Method for IgG Quantification. Int. Sch. Res. Not. 2014, 2014, 48710. [CrossRef] · DOI
- Frostell, Å.; Mattsson, A.; Eriksson, Å.; Wallby, E.; Kärnhall, J.; Illarionova, N.B.; Nilsson, C.E. Nine surface plasmon resonance assays for specific protein quantitation during cell culture and process development. Anal. Biochem. 2015, 477, 1-9. [CrossRef] · DOI
- Zschätzsch, M.; Ritter, P.; Henseleit, A.; Wiehler, K.; Malik, S.; Bley, T.; Walther, T.; Boschke, E. Monitoring bioactive and total antibody concentrations for continuous process control by surface plasmon resonance spectroscopy. Eng. Life Sci. 2019, 19, 681-690. [CrossRef] · DOI
- Yu, Y.; Mitchell, S.; Lynaugh, H.; Brown, M.; Nobrega, R.P.; Zhi, X.; Sun, T.; Caffry, I.; Cao, Y.; Yang, R.; et al. Understanding ForteBio's Sensors for High-Throughput Kinetic and Epitope Screening for Purified Antibodies and Yeast Culture Supernatant. J. Biomol. Screen. 2016, 21, 88-95. [CrossRef] · DOI
- Wang, Y.; Feng, P.; Sosic, Z.; Zang, L. Monitoring Glycosylation Profile and Protein Titer in Cell Culture Samples Using ZipChip CE-MS. J. Anal. Bioanal. Technol. 2017, 8. [CrossRef] · DOI
- Pedersen, M.E.; Østergaard, J.; Jensen, H. In-Solution IgG Titer Determination in Fermentation Broth Using Affibodies and Flow-Induced Dispersion Analysis. ACS Omega 2020, 5, 10519-10524. [CrossRef] [PubMed] · DOI
- Swartz, A.R.; Chen, W. Rapid Quantification of Monoclonal Antibody Titer in Cell Culture Harvests by Antibody-Induced Z-ELP-E2 Nanoparticle Cross-Linking. Anal. Chem. 2018, 90, 14447-14452. [CrossRef] [PubMed] · DOI
- Chemmalil, L.; Prabhakar, T.; Kuang, J.; West, J.; Tan, Z.; Ehamparanathan, V.; Song, Y.; Xu, J.; Ding, J.; Li, Z. Online/at-line measurement, analysis and control of product titer and critical product quality attributes (CQAs) during process development. Biotechnol. Bioeng. 2020. [CrossRef] · DOI
- Willets, K.A.; Van Duyne, R.P. Localized Surface Plasmon Resonance Spectroscopy and Sensing. Annu. Rev. Phys. Chem. 2007, 58, 267-297. [CrossRef] · DOI
- Bhagawati, M.; You, C.; Piehler, J. Quantitative Real-Time Imaging of Protein-Protein Interactions by LSPR Detection with Micropatterned Gold Nanoparticles. Anal. Chem. 2013, 85, 9564-9571. [CrossRef] [PubMed] · DOI
- Liu, Y.; Zhang, N.; Li, P.; Yu, L.; Chen, S.; Zhang, Y.; Jing, Z.; Peng, W. Low-Cost Localized Surface Plasmon Resonance Biosensing Platform with a Response Enhancement for Protein Detection. Nanomaterials 2019, 9, 1019. [CrossRef] [PubMed] · DOI
- Chavane, N.; Jacquemart, R.; Hoemann, C.D.; Jolicoeur, M.; De Crescenzo, G. At-line quantification of bioactive antibody in bioreactor by surface plasmon resonance using epitope detection. Anal. Biochem. 2008, 378, 158-165. [CrossRef] [PubMed] · DOI
- Hampson, G.; Ward, T.H.; Cummings, J.; Bayne, M.; Tutt, A.; Cragg, M.S.; Dive, C.; Illidge, T.M. Validation of an ELISA for the determination of rituximab pharmacokinetics in clinical trials subjects. J. Immunol. Methods 2010, 360, 30-38. [CrossRef] [PubMed] · DOI
- Liu, X.F.; Wang, X.; Weaver, R.J.; Calliste, L.; Xia, C.; He, Y.J.; Chen, L. Validation of a gyrolab™ assay for quantification of rituximab in human serum. J. Pharmacol. Toxicol. Methods 2012, 65, 107-114. [CrossRef] · DOI
- Satzer, P.; Jungbauer, A. High-capacity protein A affinity chromatography for the fast quantification of antibodies: Two-wavelength detection expands linear range. J. Sep. Sci. 2018, 41, 1791-1797. [CrossRef · DOI
Cited by
Sorted by citations
Current PAT Landscape in the Downstream Processing of Biopharmaceuticals
Sathiyapriyan, P., Mukherjee, S., Vogel, T., Essen, L., Boerema, D., Vey, M., & Kalina, U. (2025) · Analytical Science Advances · doi:10.1002/ansa.70013 · Cited by 45 · see citing works
- Authors
- Tran, T., Eskilson, O., Mayer, F., Gustavsson, R., Selegård, R., Lundström, I., Mandenius, C.-F., Martinsson, E., & Aili, D.
- Affiliations
- Laboratory of Molecular Materials, Division of Biophysics and Bioengineering, Department of Physics, Chemistry and Biology, Linköping University, 581 83 Linköping, Sweden
- Laboratory of Biotechnology, Division of Biophysics and Bioengineering, Department of Physics, Chemistry and Biology, Linköping University, 581 83 Linköping, Sweden
- Sensor and Actuator Systems, Department of Physics, Chemistry and Biology, Linköping University, 581 83 Linköping, Sweden
- ArgusEye AB, Spannmålsgatan 55, 583 36 Linköping, Sweden
- Venue
- Processes
- Publisher
- MDPI AG
- Published
- 2020-10-16
- Volume
- 8
- Issue
- 10
- Pages
- 1302
- ISSN
- 2227-9717
- Cited by
- 22
- References
- 0
- Language
- en
- Funders
- European Union’s Horizon 2020 research and innovation programme, Marie Skłodowska-Curie Actions (No. 841373)
- Swedish Innovation Agency (VINNOVA) (2016-04120 and 2019-00130)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review